salvinorin a has been researched along with glucose, (beta-d)-isomer in 1 studies
| Studies (salvinorin a) | Trials (salvinorin a) | Recent Studies (post-2010) (salvinorin a) | Studies (glucose, (beta-d)-isomer) | Trials (glucose, (beta-d)-isomer) | Recent Studies (post-2010) (glucose, (beta-d)-isomer) |
|---|---|---|---|---|---|
| 247 | 7 | 128 | 21,956 | 883 | 10,747 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capasso, R; Guerra, G; Izzo, AA; Pace, S; Pagano, E; Rossi, A; Roviezzo, F; Tedesco, F; Troisi, F; Werner, M; Werz, O; Zjawiony, JK | 1 |
1 other study(ies) available for salvinorin a and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
The hallucinogenic diterpene salvinorin A inhibits leukotriene synthesis in experimental models of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acid; Diterpenes; Diterpenes, Clerodane; Hallucinogens; Inflammation; Leukotriene Antagonists; Leukotriene B4; Macrophages, Peritoneal; Mice; Models, Theoretical; Rats; Rats, Wistar; Zymosan | 2016 |